Talga Group (TLG) H2 2026 earnings summary

Executive summary

• FY2026 marked a shift from product qualification toward early commercialisation, with commercial Talnode®-C deliveries under the binding Nyobolt offtake and FEED technical packages completed on time and on budget.

• The strategy pivoted to staged, modular production, initially using existing graphite stockpiles and scaling capacity against supply agreements; project development remains subject to funding and a final investment decision.

Financial highlights

• FY2026 revenue from product sales was A$200,727, versus A$106,168 in FY2025; other income was A$1.82m, including A$1.11m of R&D project grants.

• Net loss was A$19.46m, wider than A$16.73m in FY2025; basic and diluted loss per share were both 4.03 cents, versus 3.90 cents.

• Cash and cash equivalents were A$18.67m at 30 June 2026, versus A$13.18m; A$7.46m was restricted to approved Industriklivet project spending.

• Operating cash outflow was A$16.02m, down from A$23.67m in FY2025; plant and equipment additions were A$15.08m, including grant-funded project construction.

• A$1.31m impairment followed the German R&D facility wind-down; impairment was based on estimated fair value less disposal costs, using Level 3 inputs.

Outlook and guidance

• FEED is intended to support a Class 3 estimate for the proposed 19,500 tpa anode project; execution contracts are targeted subject to funding, approvals and FID.

• The binding Nyobolt agreement covers 3,000 tonnes over four years; similar volumes are expected from the EVA plant pending transition to the planned commercial-scale plant.

• Four post-year-end non-binding LOIs cover Talnode®-C supply to Mitsubishi Chemical Corporation, Dainen Materials, Hanwa and EAS Batteries; conversion to binding agreements is uncertain.

• Funding plans combine customer and strategic investor participation with public funding; a conditional €150m EIB facility and €70m European Commission grant have been secured, alongside pursuit of further support.